The role of diet and nutraceuticals in the amelioration of multidrug resistance amongst cancer patients

dc.contributor.authorSinghvi, Gautam
dc.contributor.authorTaliyan, Rajeev
dc.date.accessioned2025-11-10T10:54:35Z
dc.date.available2025-11-10T10:54:35Z
dc.date.issued2025-11
dc.description.abstractCancer is one of the leading causes of death globally, with the reported numbers rising every year. Although the medical fraternity has made considerable progress in early detection and treatment interventions, the numbers are expected to increase drastically by 2040. The most prevalent cause of mortality in people with diverse cancer types is likely multidrug resistance (MDR). As per recent reports, there have been increased incidences of cancer being reported globally, with projections of low-Human Development Index (HDI) countries being affected more in the near future.en_US
dc.identifier.urihttps://link.springer.com/article/10.1186/s43088-025-00706-x
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/20004
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.subjectPharmacyen_US
dc.subjectCancer mortalityen_US
dc.subjectMultidrug resistance (MDR)en_US
dc.subjectGlobal cancer incidenceen_US
dc.subjectLow-HDI countries impacten_US
dc.titleThe role of diet and nutraceuticals in the amelioration of multidrug resistance amongst cancer patientsen_US
dc.typeArticleen_US

Files